RARE
Price
$31.69
Change
-$0.33 (-1.03%)
Updated
Oct 14 closing price
Capitalization
3.05B
20 days until earnings call
Intraday Buy/Sell Signals
TRDA
Price
$6.06
Change
+$0.25 (+4.30%)
Updated
Oct 14 closing price
Capitalization
230.89M
27 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

RARE vs TRDA

Header iconRARE vs TRDA Comparison
Open Charts RARE vs TRDABanner chart's image
Ultragenyx Pharmaceutical
Price$31.69
Change-$0.33 (-1.03%)
Volume$1.23M
Capitalization3.05B
Entrada Therapeutics
Price$6.06
Change+$0.25 (+4.30%)
Volume$165.15K
Capitalization230.89M
RARE vs TRDA Comparison Chart in %
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RARE vs. TRDA commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RARE is a Hold and TRDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (RARE: $31.69 vs. TRDA: $6.06)
Brand notoriety: RARE and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RARE: 80% vs. TRDA: 59%
Market capitalization -- RARE: $3.05B vs. TRDA: $230.89M
RARE [@Biotechnology] is valued at $3.05B. TRDA’s [@Biotechnology] market capitalization is $230.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RARE’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • RARE’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RARE’s TA Score shows that 6 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • RARE’s TA Score: 6 bullish, 4 bearish.
  • TRDA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RARE is a better buy in the short-term than TRDA.

Price Growth

RARE (@Biotechnology) experienced а +6.56% price change this week, while TRDA (@Biotechnology) price change was +3.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

RARE is expected to report earnings on Nov 04, 2025.

TRDA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($3.05B) has a higher market cap than TRDA($231M). RARE YTD gains are higher at: -24.673 vs. TRDA (-64.951). TRDA has higher annual earnings (EBITDA): -92.26M vs. RARE (-435.33M). RARE has more cash in the bank: 477M vs. TRDA (354M). RARE has less debt than TRDA: RARE (36.3M) vs TRDA (54.7M). RARE has higher revenues than TRDA: RARE (610M) vs TRDA (79.5M).
RARETRDARARE / TRDA
Capitalization3.05B231M1,322%
EBITDA-435.33M-92.26M472%
Gain YTD-24.673-64.95138%
P/E RatioN/A10.05-
Revenue610M79.5M767%
Total Cash477M354M135%
Total Debt36.3M54.7M66%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
22

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RARETRDA
RSI
ODDS (%)
Bearish Trend 13 days ago
81%
N/A
Stochastic
ODDS (%)
Bearish Trend 8 days ago
72%
Bearish Trend 8 days ago
90%
Momentum
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 8 days ago
86%
MACD
ODDS (%)
Bullish Trend 8 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
75%
Bullish Trend 8 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 8 days ago
82%
Bullish Trend 8 days ago
84%
Advances
ODDS (%)
Bullish Trend 13 days ago
78%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
81%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 8 days ago
74%
Bearish Trend 8 days ago
79%
Aroon
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 8 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DASVX15.340.26
+1.72%
Dunham Small Cap Value A
FTVSX33.340.55
+1.68%
FullerThaler Behav Md-Cp Val Instl
BEGIX22.120.22
+1.00%
Sterling Capital Equity Income Instl
VMGMX125.850.31
+0.25%
Vanguard Mid-Cap Growth Index Admiral
AFEIX57.71-0.10
-0.17%
American Century Large Cap Equity I

RARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, RARE has been closely correlated with MREO. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if RARE jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RARE
1D Price
Change %
RARE100%
-1.03%
MREO - RARE
71%
Closely correlated
-2.00%
NRIX - RARE
48%
Loosely correlated
-5.56%
IONS - RARE
47%
Loosely correlated
+1.10%
TRDA - RARE
47%
Loosely correlated
+4.30%
NUVL - RARE
47%
Loosely correlated
-5.67%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+4.30%
XNCR - TRDA
54%
Loosely correlated
-10.96%
IDYA - TRDA
51%
Loosely correlated
+1.12%
NRIX - TRDA
50%
Loosely correlated
-5.56%
CRNX - TRDA
50%
Loosely correlated
-0.86%
VYGR - TRDA
49%
Loosely correlated
+1.84%
More